LIA
VNDA icon

LS Investment Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

LS Investment Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-1,750
Closed -$20K – 1444
2020
Q2 		$20K Hold
1,750
– – ﹤0.01% 1400
2020
Q1 		$18K Hold
1,750
– – ﹤0.01% 1398
2019
Q4 		$29K Sell
1,750
-2,036
-54% -$30.8K ﹤0.01% 1460
2019
Q3 		$50K Hold
3,786
– – ﹤0.01% 1303
2019
Q2 		$53K Hold
3,786
– – ﹤0.01% 1289
2019
Q1 		$70K Buy
3,786
+124
+3% +$2.83K ﹤0.01% 1203
2018
Q4 		$96K Buy
3,662
+1,912
+109% +$45K 0.01% 1072
2018
Q3 		$40K Buy
+1,750
New +$35.7K ﹤0.01% 1408

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

LS Investment Advisors's VNDA Position: Q3 2020 in Review

LS Investment Advisors sold out of Vanda Pharmaceuticals (VNDA) in Q3 2020, closing a stake of 1,750 shares — an estimated $20K sold.

LS Investment Advisors first reported a position in VNDA in Q3 2018 and held it in 8 quarters. The position peaked at $96K in Q4 2018. 164 funds tracked by Wall St. Rank hold VNDA as of Q3 2020.

  • LS Investment Advisors reported no remaining Vanda Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • LS Investment Advisors sold 1,750 Vanda Pharmaceuticals shares in Q3 2020, an estimated $20K.
  • LS Investment Advisors first reported a position in Vanda Pharmaceuticals in Q3 2018 and held it in 8 quarters.
  • LS Investment Advisors's Vanda Pharmaceuticals position peaked at $96K in Q4 2018.
  • 164 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q3 2020.

Based on LS Investment Advisors's 13F filing for Q3 2020, filed 12 Nov 2020.